Am. J. Respir. Cell Mol. Biol., Vol 10, No. 1, Jan 1994, 72-78.
HIV-1 in human alveolar macrophages from infected patients is latent in vivo but replicates after in vitro stimulation
F Lebargy, A Branellec, L Deforges, J Bignon and JF Bernaudin
INSERM U 139, Hopital Henri Mondor, Creteil, France.
It has been demonstrated that alveolar macrophages (AM) are permissive for
human immunodeficiency virus (HIV-1) after in vitro infection. However,
data concerning in vivo infection of AM by HIV-1 still conflict. Therefore,
we investigated AM collected by bronchoalveolar lavage from 15
HIV-1-infected patients. HIV-1 p24 and Gp120 antigens and viral RNA were
not detected by immunocytochemistry and in situ hybridization,
respectively, using 35S-labeled 3 kb Pol-Env, 0.350 kb Gag, and 0.150 kb U5
LTR cRNA probes. In contrast, when using polymerase chain reaction on DNA
extracted from purified AM, HIV-1 DNA was detected in the seven patients
tested. After short-term culture of alveolar cells from three
HIV-1-infected patients and in vitro stimulation with
granulocyte/macrophage colony-stimulating factor (GM- CSF) and tumor
necrosis factor-alpha (TNF-alpha), HIV-1 replication was observed in most
of the AM. These results demonstrate that AM are latently infected by HIV-1
in vivo but are not a site for viral replication. In contrast, HIV-1
replication occurs when AM are withdrawn from their local environment,
enhanced by GM-CSF and TNF- alpha stimulation. This suggests either a
negative control or an inadequate stimulation of HIV-1 replication in the
alveolar environment.
This article has been cited by other articles:

|
 |

|
 |
 
J. Rice, R. Connor, S. Worgall, J. P. Moore, P. L. Leopold, R. J. Kaner, and R. G. Crystal
Inhibition of HIV-1 Replication in Alveolar Macrophages by Adenovirus Gene Transfer Vectors
Am. J. Respir. Cell Mol. Biol.,
August 1, 2002;
27(2):
214 - 219.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Kutsch, E. N. Benveniste, G. M. Shaw, and D. N. Levy
Direct and Quantitative Single-Cell Analysis of Human Immunodeficiency Virus Type 1 Reactivation from Latency
J. Virol.,
July 29, 2002;
76(17):
8776 - 8786.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Lee, G. Leslie, E. Soilleux, U. O'Doherty, S. Baik, E. Levroney, K. Flummerfelt, W. Swiggard, N. Coleman, M. Malim, et al.
cis Expression of DC-SIGN Allows for More Efficient Entry of Human and Simian Immunodeficiency Viruses via CD4 and a Coreceptor
J. Virol.,
December 15, 2001;
75(24):
12028 - 12038.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. IEONG, C. C. REARDON, S. M. LEVITZ, and H. KORNFELD
Human Immunodeficiency Virus Type 1 Infection of Alveolar Macrophages Impairs Their Innate Fungicidal Activity
Am. J. Respir. Crit. Care Med.,
September 1, 2000;
162(3):
966 - 970.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J.-M. Mathys, S. M. Melanson, D. J. Schiffer-Alberts, J. P. A. Ioannidis, H. Koziel, and P. R. Skolnik
NF-{kappa}B Modulates TNF-{alpha} Production by Alveolar Macrophages in Asymptomatic HIV-Seropositive Individuals
J. Immunol.,
February 1, 2000;
164(3):
1588 - 1594.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. K. Iwamoto, A. M. Ainsworth, and P. L. Moseley
Hyperthermia enhances cytomegalovirus regulation of HIV-1 and TNF-alpha gene expression
Am J Physiol Lung Cell Mol Physiol,
November 1, 1999;
277(5):
L1051 - L1056.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Thomas, O. K. Weinberger, B. L. Ziegler, S. Greenberg, I. Schieren, S. C. Silverstein, and J. El Khoury
Human Immunodeficiency Virus-1 env Impairs Fcgamma Receptor-Mediated Phagocytosis Via a Cyclic Adenosine Monophosphate-Dependent Mechanism
Blood,
November 1, 1997;
90(9):
3760 - 3765.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1994 American Thoracic Society.
|
|
|